Tag Archives: Melanoma Research Alliance

A Weekly Advocacy Message from Mary Woolley: No rest during “recess”!

Dear Research Advocate:

Yesterday, President Obama tweeted about the effects of sequestration on medical research. From @barackobama, “The #sequester is slowing the pace of medical research, delaying the discovery of cures and treatments. Read more.” It is terrific that the president is helping drive increased attention to medical research. Our thanks to him and also to all who have joined our Memorial Day recess week of social media advocacy. The American Heart Association posted this great image to its Facebook page; we also thank Society for Neuroscience, BIO, The Endocrine Society, Melanoma Research Alliance, University of Maryland School of Medicine, CURE Epilepsy and UPenn Science Policy — among many others — who have participated. Now it’s your turn; let’s kick this campaign into high gear as we wrap up the week!

We know from our regularly commissioned polls that Americans value the work of our taxpayer-supported health agencies. In a recent Gallup poll, the CDC received the best reviews among 10 federal agencies surveyed. Take advantage of this news hook to translate public support into policy-maker action. CDC funding has been subjected to budget cut after budget cut, compromising the agency’s ability to safeguard the health of Americans against pandemics, bioterrorism, drug-resistant strains of infectious disease, and other predictable and unpredictable public health threats. Everyday Americans appear to value CDC more than our policy makers do. Tell your elected representatives: Let’s get past this disconnect; stand up for the CDC.

Research!America has been highlighting the importance of tackling global killers like HIV/AIDS, malaria, TB and neglected tropical diseases (NTDs) during USAID’s Global Health Month. Elected officials and the policy media are often surprised to learn that global health research and development is an integral part of the public and private sector-funded research enterprise in this country. The National Law Review’s coverage (article) of global health has highlighted Research!America’s Top 10 Reasons Why the U.S. Should Invest in Global Health Research & Development. Check it out, and if it whets your appetite for more, take a look at our video about NTDs. Typically not thought of as a problem in the U.S., NTDs are now a significant threat here. We simply must put research to work to stay ahead of the curve — to help our international friends and to maintain health and prosperity at home.

Sincerely,

Mary Woolley

Advertisements

Member spotlight: The Melanoma Research Alliance

By Wendy K. D. Selig, president and CEO of Melanoma Research Alliance

The Melanoma Research Alliance (MRA), a unique non-profit organization that funds the most promising melanoma research, was founded in 2007 by Debra and Leon Black under the auspices of the Milken Institute. In just six years, MRA has become the largest private funder of melanoma research and has awarded almost $48 million to 116 different research programs worldwide. MRA-supported projects are dedicated to accelerating progress toward the prevention, detection and treatment of deadly skin cancer.

In order to raise awareness of this disease and the need to invest in research for live-saving treatments, we are participating in Melanoma Awareness Month during the month of May. Investment in melanoma research is still sorely needed—the incidence of the disease is increasing across all segments of the population, including young adults and children. Melanoma is the most common cancer among men and women aged 25-29 and takes one life in the U.S. every hour.

Continue reading →